Literature DB >> 26844707

Prevalence and Correlates of Disruptive Mood Dysregulation Disorder Among Adolescents with Bipolar Disorder.

Rachel H B Mitchell1, Vanessa Timmins2, Jordan Collins2, Antonette Scavone2, Adam Iskric2, Benjamin I Goldstein2.   

Abstract

OBJECTIVE: The purpose of this study was to examine the prevalence and correlates of disruptive mood dysregulation disorder phenotype (DMDDP) in a clinical population of adolescents with bipolar disorder (BD).
METHODS: DMDD criteria were modified and applied to a sample of 116 adolescents with BD-I (n = 30), BD-II (n = 46) or BD-not otherwise specified (NOS) (n = 40) from a tertiary teaching hospital. Diagnoses were determined via the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Aged Children, Present and Lifetime version (KSADS-PL). Diagnostic and Statistical Manual of Mental Disorders (DSM-5) DMDD Criteria A-G were derived from the KSADS oppositional defiant disorder (ODD) screening interview and supplement, as well as narrative summaries. Chi-square analyses or t tests (p < 0.05) were conducted as appropriate, followed by logistic regression. P values were adjusted using the false discovery rate (FDR) approach.
RESULTS: DMDDP criteria could not be determined for 8 adolescents because of missing data from the ODD supplement. Twenty-five percent of the remainder (27/108) met criteria for DMDDP. DMDDP was not associated with BD subtype or with family history of BD. In univariate analyses, after controlling for age, sex, and race, DMDDP was associated with lower functioning, increased family conflict, assault history, and attention deficit and/or hyperactivity disorder (ADHD) (FDR adjusted p values: <0.0001, < 0.0001, 0.007, and 0.007, respectively). Lifetime substance use disorder and medication use approached significance (adjusted p = 0.05). In logistic regression, DMDDP was independently associated with greater parent-reported family conflict (odds ratio [OR] 1.17; confidence interval [CI- 1.06-1.30; p = 0.001) and greater functional impairment (OR 0.89; CI 0.82-0.97; p = 0.006). DMDDP was also associated with a threefold increase in ADHD, although ADHD was only marginally significant (OR 3.3; CI 0.98-10.94; p = 0.05).
CONCLUSIONS: Despite the positioning of DMDD as phenotypically and biologically distinct from BD, these phenotypes commonly overlap in clinical settings. This overlap is not explained by BD-NOS or by nonfamilial BD. The association of ADHD with DMDDP in this sample draws into question whether arousal symptoms should have been retained as originally elaborated in the severe mood dysregulation phenotype. Strategies to mitigate the excessive functional impairment of this comorbidity are warranted.

Entities:  

Mesh:

Year:  2016        PMID: 26844707     DOI: 10.1089/cap.2015.0063

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  8 in total

1.  The Clinician Affective Reactivity Index: Validity and Reliability of a Clinician-Rated Assessment of Irritability.

Authors:  Simone P Haller; Katharina Kircanski; Argyris Stringaris; Michal Clayton; Hong Bui; Courtney Agorsor; Sofia I Cardenas; Kenneth E Towbin; Daniel S Pine; Ellen Leibenluft; Melissa A Brotman
Journal:  Behav Ther       Date:  2019-11-27

Review 2.  Issues on the diagnosis and etiopathogenesis of mood disorders: reconsidering DSM-5.

Authors:  Kazuyoshi Ogasawara; Yukako Nakamura; Hiroyuki Kimura; Branko Aleksic; Norio Ozaki
Journal:  J Neural Transm (Vienna)       Date:  2017-12-23       Impact factor: 3.575

3.  Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder.

Authors:  Drew E Winters; Sadaaki Fukui; Ellen Leibenluft; Leslie A Hulvershorn
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-04-30       Impact factor: 2.576

4.  The morbidity of subthreshold pediatric bipolar disorder: A systematic literature review and meta-analysis.

Authors:  Carrie A H Vaudreuil; Stephen V Faraone; Maura Di Salvo; Janet R Wozniak; Rebecca A Wolenski; Nicholas W Carrellas; Joseph Biederman
Journal:  Bipolar Disord       Date:  2018-12-19       Impact factor: 6.744

Review 5.  Diagnostic instruments for the assessment of disruptive mood dysregulation disorder: a systematic review of the literature.

Authors:  Ines Mürner-Lavanchy; Michael Kaess; Julian Koenig
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-07-07       Impact factor: 4.785

6.  Is Irritability a Top Problem in Youth Mental Health Care? A Multi-informant, Multi-method Investigation.

Authors:  Spencer C Evans; Katherine A Corteselli; Audrey Edelman; Hannah Scott; John R Weisz
Journal:  Child Psychiatry Hum Dev       Date:  2022-01-22

Review 7.  The International Society for Bipolar Disorders Task Force report on pediatric bipolar disorder: Knowledge to date and directions for future research.

Authors:  Benjamin I Goldstein; Boris Birmaher; Gabrielle A Carlson; Melissa P DelBello; Robert L Findling; Mary Fristad; Robert A Kowatch; David J Miklowitz; Fabiano G Nery; Guillermo Perez-Algorta; Anna Van Meter; Cristian P Zeni; Christoph U Correll; Hyo-Won Kim; Janet Wozniak; Kiki D Chang; Manon Hillegers; Eric A Youngstrom
Journal:  Bipolar Disord       Date:  2017-09-25       Impact factor: 6.744

Review 8.  Disruptive mood dysregulation disorder: current insights.

Authors:  Raman Baweja; Susan D Mayes; Usman Hameed; James G Waxmonsky
Journal:  Neuropsychiatr Dis Treat       Date:  2016-08-24       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.